- Home
- LSEA vs NVCT Comparison
LSEA vs NVCT Comparison
Compare LSEA & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSEA
- NVCT
- Stock Information
- Founded
- LSEA 2013
- NVCT 2020
- Country
- LSEA United States
- NVCT United States
- Employees
- LSEA N/A
- NVCT N/A
- Industry
- LSEA Homebuilding
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- LSEA Consumer Discretionary
- NVCT Health Care
- Exchange
- LSEA Nasdaq
- NVCT Nasdaq
- Market Cap
- LSEA 222.1M
- NVCT 249.1M
- IPO Year
- LSEA N/A
- NVCT 2022
- Fundamental
- Price
- LSEA $6.77
- NVCT $8.94
- Analyst Decision
- LSEA Buy
- NVCT Strong Buy
- Analyst Count
- LSEA 4
- NVCT 3
- Target Price
- LSEA $13.50
- NVCT $17.00
- AVG Volume (30 Days)
- LSEA 200.4K
- NVCT 159.9K
- Earning Date
- LSEA 05-12-2025
- NVCT 05-06-2025
- Dividend Yield
- LSEA N/A
- NVCT N/A
- EPS Growth
- LSEA N/A
- NVCT N/A
- EPS
- LSEA 0.47
- NVCT N/A
- Revenue
- LSEA $1,550,337,000.00
- NVCT N/A
- Revenue This Year
- LSEA N/A
- NVCT N/A
- Revenue Next Year
- LSEA $3.52
- NVCT N/A
- P/E Ratio
- LSEA $12.98
- NVCT N/A
- Revenue Growth
- LSEA 28.13
- NVCT N/A
- 52 Week Low
- LSEA $5.41
- NVCT $4.44
- 52 Week High
- LSEA $14.04
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- LSEA 50.93
- NVCT 49.58
- Support Level
- LSEA $5.79
- NVCT $8.01
- Resistance Level
- LSEA $6.60
- NVCT $9.62
- Average True Range (ATR)
- LSEA 0.33
- NVCT 1.02
- MACD
- LSEA 0.05
- NVCT -0.14
- Stochastic Oscillator
- LSEA 53.09
- NVCT 34.94
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.